SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO)(STO:AERO-B) today announced that NICE (National Institute for Health and Care Excellence) has published guidelines(http://www.nice.org.uk/newsroom/news/SimpleTestToHelpDiagnoseAndManageAsthma.jsp) recommending the use of Aerocrine’s NIOX MINO® and NIOX VERO® to help guide the diagnosis and management of asthma in both adults and children.
Help employers find you! Check out all the jobs and post your resume.
